Literature DB >> 3128977

Induction of indoleamine dioxygenase by interferon in mice: a study with different recombinant interferons and various cytokines.

M Bianchi1, R Bertini, P Ghezzi.   

Abstract

Since it is important the availability of a specific marker for interferon induction in vivo, we investigated the effect of different recombinant interferons and various cytokines on indoleamine 2,3-dioxygenase activity. Although with different magnitude, recombinant interferon-alpha A/D (Bgl II) hybrid, interferon-gamma and tumor necrosis factor, all increase the activity of this enzyme, whereas interleukin-1, recombinant interferon-alpha A and interferon-alpha D do not induce this activity in mice lung tissue. Dexamethasone is able to inhibit indoleamine 2,3-dioxygenase induction by lipopolysaccharide or by interferon-alpha A/D but it fails to prevent the induction by interferon-gamma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128977     DOI: 10.1016/s0006-291x(88)80705-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.

Authors:  L A Sanni; S R Thomas; B N Tattam; D E Moore; G Chaudhri; R Stocker; N H Hunt
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

2.  Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.

Authors:  Jennifer E Cole; Nagore Astola; Adam P Cribbs; Michael E Goddard; Inhye Park; Patricia Green; Alun H Davies; Richard O Williams; Marc Feldmann; Claudia Monaco
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

3.  Interferon gamma-resistant mutants are defective in the induction of indoleamine 2,3-dioxygenase.

Authors:  G S Feng; M W Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival.

Authors:  Sarah S Zaher; Conrad Germain; Hongmei Fu; Daniel F P Larkin; Andrew J T George
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-22       Impact factor: 4.799

5.  Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III).

Authors:  S J Gebran; Y Yamamoto; C Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Immunocytochemical localization of the endogenous neuroexcitotoxin quinolinate in human peripheral blood monocytes/macrophages and the effect of human T-cell lymphotropic virus type I infection.

Authors:  C N Venkateshan; R Narayanan; M G Espey; J R Moffett; D C Gajdusek; C J Gibbs; M A Namboodiri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

7.  Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells.

Authors:  Nermin Serbecic; Imad Lahdou; Alexander Scheuerle; Romana Höftberger; Fahmy Aboul-Enein
Journal:  Mol Vis       Date:  2009-07-08       Impact factor: 2.367

8.  Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection.

Authors:  Julie M Fox; Jackelyn M Crabtree; Leo K Sage; S Mark Tompkins; Ralph A Tripp
Journal:  J Interferon Cytokine Res       Date:  2015-03-10       Impact factor: 2.607

9.  Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases.

Authors:  S Christen; E Peterhans; R Stocker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

10.  Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.

Authors:  Peter Terness; Thomas M Bauer; Lars Röse; Christoph Dufter; Andrea Watzlik; Helmut Simon; Gerhard Opelz
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.